• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

MED RESEARCH BILL “BETTER THAN NOTHING”

By Alex Halperin
09/13/2020 07:55 PM GMT-0700
FacebookTweetPin

WeedWeek columnist Dan Mitchell discusses the Medical Marijuana Research Act (MMRA) a bill which would lift some of the restrictions on MED research.

  • Among other things, the bill would allow the use of state-licensed product for research purposes, as opposes to the notoriously poor product grown at the federally permitted facility at the University of Mississippi.
  • The bill is expected to pass the full House of Representatives, but its prospects in the GOP controlled Senate are bleak.
  • Bob Solomon of the University of California – Irvine’s Center for the Study of Cannabis, called the bill “better than nothing, but not much better.”
  • The MMRA has support from some prohibitionists, such as Kevin Sabet-led group Smart Approaches to Marijuana. They may suspect more research would show that MED isn’t as beneficial as many supporters believe.

Share:
FacebookTweetPin
Filed Under:
Federal

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: Financial Strategy Implications of Rescheduling

Duration Broadcast March 26th
Speakers Gail Rand, Alex Halperin

WATCH NOW

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Federal Articles
Financial
Federal

WeedWeek Wonks: Financial Strategy Implications of Rescheduling

cann
Beverages

Newsbrief: Hemp drink fight continues in D.C.

David Kay
Industry Voices

Industry Voices: Rescheduling Won’t Save Margins, Discipline Will

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved